Schonfeld Strategic Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,883
Closed -$276K 1497
2020
Q2
$276K Buy
+11,883
New +$255K 0.01% 1020

Other funds holding IRMD

Schonfeld Strategic Advisors's IRMD Position: Q3 2020 in Review

Schonfeld Strategic Advisors sold out of iRadimed (IRMD) in Q3 2020, closing a stake of 11,883 shares — an estimated $276K sold.

Schonfeld Strategic Advisors first reported a position in IRMD in Q2 2020 and held it in 1 quarter. The position peaked at $276K in Q2 2020. 62 funds tracked by Wall St. Rank hold IRMD as of Q3 2020.

  • Schonfeld Strategic Advisors reported no remaining iRadimed position as of Q3 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 11,883 iRadimed shares in Q3 2020, an estimated $276K.
  • Schonfeld Strategic Advisors first reported a position in iRadimed in Q2 2020 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's iRadimed position peaked at $276K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held iRadimed as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.